OLA
IRWD icon

Oliver Luxxe Assets’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oliver Luxxe Assets’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,078
Closed -$301K – 206
2021
Q3 		$301K Buy
+23,078
New +$298K 0.08% 167

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Oliver Luxxe Assets's IRWD Position: Q4 2021 in Review

Oliver Luxxe Assets sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 23,078 shares — an estimated $301K sold.

Oliver Luxxe Assets first reported a position in IRWD in Q3 2021 and held it in 1 quarter. The position peaked at $301K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Oliver Luxxe Assets reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Oliver Luxxe Assets sold 23,078 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $301K.
  • Oliver Luxxe Assets first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Oliver Luxxe Assets's Ironwood Pharmaceuticals position peaked at $301K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Oliver Luxxe Assets's 13F filing for Q4 2021, filed 4 Feb 2022.